CIPN OT Oncology, ListServ Summary, Mar 2026

Rehab administrators answer questions regarding CIPN – OT Oncology. IPRC archives information collected by the Pediatric Rehab Administrator’s ListServ as a public service to the entire Pediatric Rehabilitation Community. All information is posted in summary format and has been de-identified. Search through past queries for responses to rehabilitation related questions.

Original Question(s):

1. What is the name of your institution?
2. What type of institution do you work in?
3. What rehabilitation discipline do you work in? 
4. Within the rehabilitation program, what rehabilitation disciplines are provided for pediatric oncology patients? (Select all that apply) 
5. Within the rehabilitation program, in which settings are pediatric oncology OT services provided? (Select all that apply)
6. At your institution, are there occupational therapists who only treat pediatric oncology patients, or is occupational therapy provided to oncology patients by general pediatric therapists? Do OTRs/COTAs receive training in pediatric oncology rehabilitation?
7. As part of your rehabilitation program, is CIPN assessment performed? Who is primarily responsible for assessing CIPN at your institution?
8. Once CIPN is diagnosed, is there a standardized treatment plan that is followed at your institution?
9. At your institution, is there a standarized plan of care for OT services for pediatric oncology patients? 
10. Within the standardized plan of care, how frequently is OT intervention typically provided for pediatric oncology patients with CIPN? 
11. In the absense of a standarized plan of care, what is the typical follow-up interval for pediatric oncology patients with CIPN? 
12. At your institution, is there a grading system set in place for severity of CIPN symptoms?  Please explain how this impacts the treatment of CIPN symptoms and describe the grading system used. 
13. Does your institution perform genetic testing for genes associated with CIPN?  If applicable, please describe how genetic testing influences your approach to addressing CIPN in pediatric oncology patients? 
14. Are there any additional comments or recommendations related to OT for pediatric oncology patients or intervention for CIPN symptoms you would like to share? 

Summary of Responses (de-identified)